Australia's largest stock trading and investment forum Australia's #1 stock forum

BTA

Click for more information

0.00%

57.0¢ biota holdings limited

It obviously worked for reducing the virus load, boosting the...

First 9 Last

Share
Profile

Follow
ML173

9,595 Posts.

310

02/08/14

11:20

Post #: 13758844
Share

Originally posted by muzzarati ↑

We were near cash backing anyway

This was all screwed up. Read this from the announcement.

Patients in both the 40 mg (p<0.001) and 80 mg (p=0.070) cohorts demonstrated a statistically significant reduction in viral shedding on Day 3 of the study compared to placebo as quantified by qRT-PCR. In addition, a statistically significant proportion of patients in both the 40 mg (p=0.002) and 80 mg (p=0.020) cohorts were culture negative on Day 3 of the study as compared to placebo. Influenza-infected patients in the 40 mg cohort also demonstrated a statistically significant reduction in the incidence of secondary bacterial infections as compared to placebo (p=0.013).

Expand

It obviously worked for reducing the virus load, boosting the immunity and prevent secondary bacteria infection like chest and throat infections after 3 days. Secondary bacteria infection is usually the thing that kill the cohorts.. Why couldn't they emphasise the study for that statistical significant endpoint ?

Last edited by ML173: 02/08/14

BTA Price at posting: 57.0¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

EXR

Essential Energy conference: Elixir talks up unlocking QLD's Taroom Trough

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

Essential Energy conference: Streamlining approvals key to the green energy transition

First 9 Last

Add BTA (ASX) to my watchlist